PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.76%
Net income growth under 50% of AVGO's 92.44%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.80%
Negative yoy D&A while AVGO is 0.52%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
56.86%
Some yoy growth while AVGO is negative at -5.28%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-16.00%
Both cut yoy SBC, with AVGO at -3.44%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
238.74%
Slight usage while AVGO is negative at -62.78%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
89.81%
AR growth while AVGO is negative at -27.86%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
82.81%
Inventory growth well above AVGO's 152.34%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
123.08%
A yoy AP increase while AVGO is negative at -86.99%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
742.31%
Some yoy usage while AVGO is negative at -91.77%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-384.38%
Negative yoy while AVGO is 15.79%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
47.26%
Operating cash flow growth above 1.5x AVGO's 5.35%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-45.21%
Negative yoy CapEx while AVGO is 2.86%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
45.21%
Some acquisitions while AVGO is negative at -554.17%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
7.44%
Purchases growth of 7.44% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
211.18%
Liquidation growth of 211.18% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-45.91%
Both yoy lines negative, with AVGO at -81.82%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
54.50%
We have mild expansions while AVGO is negative at -117.39%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-7.32%
Negative yoy issuance while AVGO is 121.74%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.